MSA Safety Incorporated (MSA) Q4 2025 Earnings Call Transcript
MSA Safety Incorporated (MSA) Q4 2025 Earnings Call Transcript
MSA Safety (MSA) Reports Q4 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for MSA Safety (MSA) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
MSA Safety (MSA) Tops Q4 Earnings and Revenue Estimates
MSA Safety (MSA) came out with quarterly earnings of $2.38 per share, beating the Zacks Consensus Estimate of $2.26 per share. This compares to earnings of $2.25 per share a year ago.
Income Investors Can Sleep Well With MSA's Dividend Despite 2023 Cash Flow Scare
MSA Safety (NYSE: MSA) pays $2.08 per share annually, yielding 1.28%.
MSA Safety Incorporated (MSA) Presents at Baird 55th Annual Global Industrial Conference Transcript
MSA Safety Incorporated ( MSA ) Baird 55th Annual Global Industrial Conference November 12, 2025 8:55 AM EST Company Participants Steven Blanco - President, CEO & Director Julie Beck - SVP, CFO & Treasurer Conference Call Participants Robert Mason - Robert W. Baird & Co. Incorporated, Research Division Presentation Robert Mason Robert W.
MSA Safety (MSA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for MSA Safety (MSA) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
MSA Safety Incorporated (MSA) Q3 2025 Earnings Call Transcript
MSA Safety Incorporated ( MSA ) Q3 2025 Earnings Call October 29, 2025 10:00 AM EDT Company Participants Lawrence De Maria - Executive Director of Investor Relations Steven Blanco - President, CEO & Director Julie Beck - SVP, CFO & Treasurer Conference Call Participants Robert Mason - Robert W. Baird & Co. Incorporated, Research Division Ross Sparenblek - William Blair & Company L.L.C.
MSA Safety (MSA) Beats Q3 Earnings and Revenue Estimates
MSA Safety (MSA) came out with quarterly earnings of $1.94 per share, beating the Zacks Consensus Estimate of $1.9 per share. This compares to earnings of $1.83 per share a year ago.
Tiziana Life Sciences doses first MSA patient in new trial – ICYMI
Tiziana Life Sciences Ltd (NASDAQ:TLSA) CEO Ivor Elrifi talked with Proactive about the company's latest milestone: dosing the first patient in its Phase 2a clinical trial targeting multiple system atrophy (MSA), a rare and fatal neurodegenerative condition with no approved treatment. Elrifi explained the trial involves the company's investigational monoclonal antibody, Foralumab, which is administered intranasally and aims to reduce neuroinflammation.
Tiziana Life Sciences doses first patient in Phase 2a MSA trial
Tiziana Life Sciences Ltd (NASDAQ:TLSA) announced that it has enrolled and dosed the first participant in its Phase 2a clinical trial evaluating intranasal foralumab in patients with Multiple System Atrophy (MSA). The trial is being conducted at Brigham and Women's Hospital in Boston, Massachusetts.
MSA Safety Incorporated (MSA) Q2 2025 Earnings Conference Call Transcript
MSA Safety Incorporated (NYSE:MSA ) Q2 2025 Earnings Call August 5, 2025 10:00 AM ET Company Participants Elyse L. Brody - Interim Chief Financial Officer Lawrence Tighe De Maria - Executive Director of Investor Relations Steven C.
MSA Safety (MSA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for MSA Safety (MSA) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
